Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes

Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes

Neuromyelitis optica spectrum disorder (NMOSD) and anti-myelin oligodendrocyte glycoprotein (anti-MOG) syndromes are immune-mediated inflammatory conditions of the central nervous system that frequently involve the optic nerves and the spinal cord. Because of their similar clinical manifestations an...

Full description

Bibliographic Details
Main Authors:	Marco A. Lana-Peixoto, Natália Talim
Format:	Article
Language:	English
Published:	MDPI AG 2019-06-01
Series:	Biomedicines
Subjects:	neuromyelitis optica spectrum disorders anti-MOG syndrome aquaporin 4-IgG myelin oligodendrocyte glycoprotein multiple sclerosis
Online Access:	https://www.mdpi.com/2227-9059/7/2/42

Similar Items

Anti-myelin Oligodendrocyte Glycoprotein in Aquaporin-4 Negative Neuromyelitis Optica Spectrum Disorder
by: Vahid Shaygannejad, et al.
Published: (2021-01-01)

Relapses and Serious Infections in Patients with Neuromyelitis Optica Spectrum Disorder Treated with Rituximab: A Swedish Single-Center Study
by: Olof Carlsson, et al.
Published: (2024-01-01)

Anti myelin oligodendrocyte glycoprotein associated immunoglobulin G (AntiMOG-IgG)-associated neuromyelitis optica spectrum disorder with persistent disease activity and residual cognitive impairment
by: Lekha Pandit, et al.
Published: (2017-01-01)

Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescents
by: Renata Barbosa Paolilo, et al.
Published: (2023-02-01)

Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Positive Patients in a Multi-Ethnic Canadian Cohort
by: Helen Cross, et al.
Published: (2021-01-01)

Evaluation of Thiol Homeostasis in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
by: Burak Arslan, et al.
Published: (2021-08-01)

Clinical Features of Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders
by: Hai Chen, et al.
Published: (2016-01-01)

Anti-B-cell therapy in patients with neuromyelitis optica spectrum disorders
by: S. V. Kotov, et al.
Published: (2021-08-01)

Positive Predictive Value of MOG-IgG for Clinically Defined MOG-AD Within a Real-World Cohort
by: Giovanna S. Manzano, et al.
Published: (2022-06-01)

MOG antibody-associated disease – a new entity or one of the forms of the NMO spectrum?
by: Dominika Czarnecka, et al.
Published: (2019-10-01)

Autoantibodies in patients with neuromyelitis optica
by: Xin FAN, et al.
Published: (2016-10-01)

Neuromyelitis Optica Spectrum Disorder: From Basic Research to Clinical Perspectives
by: Tzu-Lun Huang, et al.
Published: (2022-07-01)

CSF GFAP levels in double seronegative neuromyelitis optica spectrum disorder: no evidence of astrocyte damage
by: Jae-Won Hyun, et al.
Published: (2022-04-01)

Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders
by: Mader Simone, et al.
Published: (2011-12-01)

Neuromyelitis optica spectrum disorders and anti-myelin oligodendrocyte glycoprotein positive optic neuropathies
by: Patrick Murtagh, et al.
Published: (2022-07-01)

Efficacy and safety of rituximab in central nervous system demyelinating disorders
by: Varsha A Patil, et al.
Published: (2021-01-01)

Neuromyelitis optica - an update: 2007-2009
by: Jacob Anu
Published: (2009-01-01)

MRI Prognostic Factors in Multiple Sclerosis, Neuromyelitis Optica Spectrum Disorder, and Myelin Oligodendrocyte Antibody Disease
by: Rosa Cortese, et al.
Published: (2021-11-01)

Neuromyelitis Optica: A Case Report
by: Wei-Chia Chia, et al.
Published: (2010-12-01)

Pediatric Neuromyelitis Optica Spectrum Disorder: Case Series and Literature Review
by: Michela Ada Noris Ferilli, et al.
Published: (2021-12-01)

Treatment of Neuromyelitis Optica Spectrum Disorders
by: Koon-Ho Chan, et al.
Published: (2021-08-01)

Neuromyelitis Optica Spectrum Disorder in Central America and the Caribbean: A Multinational Clinical Characterization Study
by: Fernando Gracia, et al.
Published: (2022-03-01)

Differential diagnosis of demyelinating diseases: what's new?
by: Ana Beatriz Ayroza Galvão Ribeiro Gomes, et al.
Published: (2022-08-01)

Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Current Insights into the Disease Pathophysiology, Diagnosis and Management
by: Wojciech Ambrosius, et al.
Published: (2020-12-01)

Anti-MOG Antibody-Associated Unilateral Cortical Encephalitis with Bilateral Meningeal Involvement: A Case Report
by: Bo Ren, et al.
Published: (2023-02-01)

Potential of PINK1 and PARKIN Proteins as Biomarkers for Active Multiple Sclerosis: A Japanese Cohort Study
by: Davide Cossu, et al.
Published: (2021-08-01)

NEUROMYELITIS OPTICA SPECTRUM DISORDERS: DIAGNOSIS AND TREATMENT, THE EXPERIENCE OF CLINICAL OBSERVATIONS
by: V. D. Piven, et al.
Published: (2018-12-01)

AQP4 Antibody Assay Sensitivity Comparison in the Era of the 2015 Diagnostic Criteria for NMOSD
by: Kerri Prain, et al.
Published: (2019-10-01)

Comparative Analysis of T-Cell Responses to Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein in Inflammatory Demyelinating Central Nervous System Diseases
by: Livia Sophie Hofer, et al.
Published: (2020-06-01)

Consensus of expert advices on routing, diagnosis, and management of patients with neuromyelitis optica spectrum disorders
by: A. N. Boyko, et al.
Published: (2021-10-01)

A Rare Case Report: MOGAD with Optic Neuritis- without Spinal İnvolvement
by: Canan Akünal Türel, et al.
Published: (2023-04-01)

Neuromyelitis optica spectrum disorder: a pediatric case report
by: Mujgan Arslan, et al.
Published: (2017-09-01)

Human antibodies against the myelin oligodendrocyte glycoprotein can cause complement-dependent demyelination
by: Patrick Peschl, et al.
Published: (2017-10-01)

Anti-MOG associated myelitis
by: A. I. Isaykin, et al.
Published: (2020-06-01)

Astrocytic Interleukin-15 Reduces Pathology of Neuromyelitis Optica in Mice
by: Zhiguo Li, et al.
Published: (2018-03-01)

MRI features of myelin oligodendrocyte glycoprotein antibody disease: a descriptive study—how it differs from neuromyelitis optica spectrum disorders and multiple sclerosis
by: J. Tom Mishael, et al.
Published: (2023-07-01)

Devic’s neuromyelitis optica: a critical review Neuromielite óptica de Devic: revisão crítica
by: Marco Aurélio Lana-Peixoto
Published: (2008-03-01)

Case Series: Myelin Oligodendrocyte Glycoprotein-Immunoglobulin G-Related Disease Spectrum
by: Foziah Alshamrani, et al.
Published: (2020-02-01)

Neuromyelitis Optica: An Often Forgotten Cause of Intractable Nausea and Vomiting
by: Chijioke Enweluzo, et al.
Published: (2013-07-01)

The risk factors of neuropathic pain in neuromyelitis optica spectrum disorder: a retrospective case-cohort study
by: Xiaojun Li, et al.
Published: (2022-08-01)